177 related articles for article (PubMed ID: 33527622)
1. No evidence of EMAST in whole genome sequencing data from 248 colorectal cancers.
Kondelin J; Martin S; Katainen R; Renkonen-Sinisalo L; Lepistö A; Koskensalo S; Böhm J; Mecklin JP; Cajuso T; Hänninen UA; Välimäki N; Ravantti J; Rajamäki K; Palin K; Aaltonen LA
Genes Chromosomes Cancer; 2021 Jul; 60(7):463-473. PubMed ID: 33527622
[TBL] [Abstract][Full Text] [Related]
2. Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer.
Chen MH; Chang SC; Lin PC; Yang SH; Lin CC; Lan YT; Lin HH; Lin CH; Lai JI; Liang WY; Lu ML; Yang MH; Chao Y
Oncologist; 2019 Dec; 24(12):1534-1542. PubMed ID: 31292272
[TBL] [Abstract][Full Text] [Related]
3. Microsatellite instability at tetranucleotide repeats in sporadic colorectal cancer in Japan.
Yamada K; Kanazawa S; Koike J; Sugiyama H; Xu C; Funahashi K; Boland CR; Koi M; Hemmi H
Oncol Rep; 2010 Feb; 23(2):551-61. PubMed ID: 20043121
[TBL] [Abstract][Full Text] [Related]
4. EMAST Type of Microsatellite Instability-A Distinct Entity or Blurred Overlap between Stable and MSI Tumors.
Vuković Đerfi K; Salar A; Cacev T; Kapitanović S
Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510378
[TBL] [Abstract][Full Text] [Related]
5. MSI-L/EMAST is a predictive biomarker for metastasis in colorectal cancer patients.
Torshizi Esfahani A; Seyedna SY; Nazemalhosseini Mojarad E; Majd A; Asadzadeh Aghdaei H
J Cell Physiol; 2019 Aug; 234(8):13128-13136. PubMed ID: 30549036
[TBL] [Abstract][Full Text] [Related]
6. Lack of correlation between MSH3 immunohistochemistry and microsatellite analysis for the detection of elevated microsatellite alterations at selected tetranucleotide repeats (EMAST) in colorectal cancers.
Laycock A; Kang A; Ang S; Texler M; Bentel J
Hum Pathol; 2021 Dec; 118():9-17. PubMed ID: 34537247
[TBL] [Abstract][Full Text] [Related]
7. Genetic instability caused by loss of MutS homologue 3 in human colorectal cancer.
Haugen AC; Goel A; Yamada K; Marra G; Nguyen TP; Nagasaka T; Kanazawa S; Koike J; Kikuchi Y; Zhong X; Arita M; Shibuya K; Oshimura M; Hemmi H; Boland CR; Koi M
Cancer Res; 2008 Oct; 68(20):8465-72. PubMed ID: 18922920
[TBL] [Abstract][Full Text] [Related]
8. Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) and Microsatellite Instability in Patients with Colorectal Cancer and Its Clinical Features.
Lee HS; Park KU; Kim DW; Lhn MH; Kim WH; Seo AN; Chang HE; Nam SK; Lee SY; Oh HK; Kang SB
Curr Mol Med; 2016; 16(9):829-839. PubMed ID: 27889996
[TBL] [Abstract][Full Text] [Related]
9. Deciphering Elevated Microsatellite Alterations at Selected Tetra/Pentanucleotide Repeats, Microsatellite Instability, and Loss of Heterozygosity in Colorectal Cancers.
Wang Y; Vnencak-Jones CL; Cates JM; Shi C
J Mol Diagn; 2018 May; 20(3):366-372. PubMed ID: 29474982
[TBL] [Abstract][Full Text] [Related]
10. Patterns of germline and somatic mutations in 16 genes associated with mismatch repair function or containing tandem repeat sequences.
Chang SC; Lan YT; Lin PC; Yang SH; Lin CH; Liang WY; Chen WS; Jiang JK; Lin JK
Cancer Med; 2020 Jan; 9(2):476-486. PubMed ID: 31769227
[TBL] [Abstract][Full Text] [Related]
11. Is elevated microsatellite alterations at selected tetranucleotide repeats (EMAST)-negative/MSI-high colorectal cancer a distinct subtype of the disease?
Park Y; Kim DW; Hong YJ; Park KU; Nam SK; Na HY; Lee HS; Kim MH; Oh HK; Kang SB
J Surg Oncol; 2020 Dec; 122(7):1462-1469. PubMed ID: 32779222
[TBL] [Abstract][Full Text] [Related]
12. Inflammation-Associated Microsatellite Alterations Caused by MSH3 Dysfunction Are Prevalent in Ulcerative Colitis and Increase With Neoplastic Advancement.
Munakata K; Koi M; Kitajima T; Tseng-Rogenski S; Uemura M; Matsuno H; Kawai K; Sekido Y; Mizushima T; Toiyama Y; Yamada T; Mano M; Mita E; Kusunoki M; Mori M; Carethers JM
Clin Transl Gastroenterol; 2019 Dec; 10(12):e00105. PubMed ID: 31789935
[TBL] [Abstract][Full Text] [Related]
13. Microsatellite instability at a tetranucleotide repeat in type I endometrial carcinoma.
Choi YD; Choi J; Kim JH; Lee JS; Lee JH; Choi C; Choi HS; Lee MC; Park CS; Juhng SW; Nam JH
J Exp Clin Cancer Res; 2008 Dec; 27(1):88. PubMed ID: 19116039
[TBL] [Abstract][Full Text] [Related]
14. Immunological Features with DNA Microsatellite Alterations in Patients with Colorectal Cancer.
Raeker MO; Carethers JM
J Cancer Immunol (Wilmington); 2020; 2(3):116-127. PubMed ID: 33000102
[TBL] [Abstract][Full Text] [Related]
15. Tetranucleotide Microsatellite Mutational Behavior Assessed in Real Time: Implications for Future Microsatellite Panels.
Raeker MÖ; Pierre-Charles J; Carethers JM
Cell Mol Gastroenterol Hepatol; 2020; 9(4):689-704. PubMed ID: 31982570
[TBL] [Abstract][Full Text] [Related]
16. EMAST is associated with a poor prognosis in microsatellite instable metastatic colorectal cancer.
Venderbosch S; van Lent-van Vliet S; de Haan AF; Ligtenberg MJ; Goossens M; Punt CJ; Koopman M; Nagtegaal ID
PLoS One; 2015; 10(4):e0124538. PubMed ID: 25884216
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress induces nuclear-to-cytosol shift of hMSH3, a potential mechanism for EMAST in colorectal cancer cells.
Tseng-Rogenski SS; Chung H; Wilk MB; Zhang S; Iwaizumi M; Carethers JM
PLoS One; 2012; 7(11):e50616. PubMed ID: 23226332
[TBL] [Abstract][Full Text] [Related]
18. Microsatellite alterations at selected tetranucleotide repeats are associated with morphologies of colorectal neoplasias.
Lee SY; Chung H; Devaraj B; Iwaizumi M; Han HS; Hwang DY; Seong MK; Jung BH; Carethers JM
Gastroenterology; 2010 Nov; 139(5):1519-25. PubMed ID: 20708618
[TBL] [Abstract][Full Text] [Related]
19. Different types of microsatellite instability in ovarian carcinoma.
Singer G; Kallinowski T; Hartmann A; Dietmaier W; Wild PJ; Schraml P; Sauter G; Mihatsch MJ; Moch H
Int J Cancer; 2004 Nov; 112(4):643-6. PubMed ID: 15382045
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Adjuvant 5-Fluorouracil Therapy for Patients with EMAST-Positive Stage II/III Colorectal Cancer.
Hamaya Y; Guarinos C; Tseng-Rogenski SS; Iwaizumi M; Das R; Jover R; Castells A; Llor X; Andreu M; Carethers JM
PLoS One; 2015; 10(5):e0127591. PubMed ID: 25996601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]